These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 15280526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
    Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG.
    J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of aquaporin-2 in patients with diabetes insipidus.
    Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG, Marumo F.
    N Engl J Med; 1995 Jun 08; 332(23):1540-5. PubMed ID: 7537863
    [Abstract] [Full Text] [Related]

  • 4. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I, Baumgarten R, Movig KL, van Laarhoven J, Apperloo AJ, Nolen WA, Heerdink ER, Knoers NV, Egberts AC.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):50-7. PubMed ID: 17466972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers.
    Baumgarten R, van de Pol MH, Deen PM, van Os CH, Wetzels JF.
    Nephrol Dial Transplant; 2000 Aug 02; 15(8):1155-61. PubMed ID: 10910438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP, Marosi J, Fischer J, Takó J, Kiss N.
    Endokrinologie; 1975 Nov 02; 66(2):184-95. PubMed ID: 1236681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic dDAVP infusion in rats decreases the expression of P2Y2 receptor in inner medulla and P2Y2 receptor-mediated PGE2 release by IMCD.
    Sun R, Miller RL, Hemmert AC, Zhang P, Shi H, Nelson RD, Kishore BK.
    Am J Physiol Renal Physiol; 2005 Oct 02; 289(4):F768-76. PubMed ID: 15914777
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF, Lorentz WB, Berger M, Smith EH, Carvajal HF, Travis LB.
    Pediatr Res; 1977 Jan 02; 11(1 Pt 1):33-6. PubMed ID: 188007
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN.
    N Engl J Med; 1988 Apr 07; 318(14):881-7. PubMed ID: 2965301
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L, Julesz J, László FA.
    Int J Clin Pharmacol Biopharm; 1978 Jan 07; 16(1):10-3. PubMed ID: 631964
    [Abstract] [Full Text] [Related]

  • 15. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.
    Williams TD, Dunger DB, Lyon CC, Lewis RJ, Taylor F, Lightman SL.
    J Clin Endocrinol Metab; 1986 Jul 07; 63(1):129-32. PubMed ID: 3711257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T, Higashiyama M, Nagasaka S, Sasaki S, Saito T, Ishikawa SE.
    Kidney Int; 2001 Oct 07; 60(4):1266-76. PubMed ID: 11576341
    [Abstract] [Full Text] [Related]

  • 18. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
    Kim GH, Lee JW, Oh YK, Chang HR, Joo KW, Na KY, Earm JH, Knepper MA, Han JS.
    J Am Soc Nephrol; 2004 Nov 07; 15(11):2836-43. PubMed ID: 15504936
    [Abstract] [Full Text] [Related]

  • 19. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ.
    Clin J Am Soc Nephrol; 2008 Sep 07; 3(5):1324-31. PubMed ID: 18596116
    [Abstract] [Full Text] [Related]

  • 20. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
    Kamsteeg EJ, Wormhoudt TA, Rijss JP, van Os CH, Deen PM.
    EMBO J; 1999 May 04; 18(9):2394-400. PubMed ID: 10228154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.